_id
6915f8d2bc934aba376b25cf
Ticker
SIGY
Name
Sigyn Therapeutics Inc
Exchange
OTCQB
Address
2468 Historic Decatur Road, San Diego, CA, United States, 92106
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.sigyntherapeutics.com
Description
Sigyn Therapeutics, Inc., a development-stage company, develops and sells medical devices to treat cancer and infectious disease disorders in the United States. Its lead product candidate is Sigyn therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community-acquired pneumonia, drug-resistant bacterial infections, and emerging pandemic threats. The company is also involved in the evaluation of Sigyn therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the performance of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.
Last Close
1.71
Volume
-
Current Price
0.5
Change
0
Last Updated
2026-01-07T11:46:49.367Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
1573269
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
0
Operating Expenses
386529
Operating Income
-386529
Interest Expense
191974
Pretax Income
-578503
Net Income
-578503
Eps
-0.3603533624812116
Dividends Per Share
-
Shares Outstanding
1605377
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
85571
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
85571
Property Plant Equipment
0
Total Assets
135571
Payables
773604
Short Term Debt
-
Long Term Debt
2063289
Total Liabilities
6052780
Equity
-5917209
Bs_currency_symbol
USD
Depreciation
0
Change In Working Capital
139227
Cash From Operations
-199326
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
284438
Net Change In Cash
85112
Cf_currency_symbol
USD
PE
-
PB
-0.13565322772949207
ROE
9.7766193487504
ROA
-426.7158905665666
FCF
-199326
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
0.5
Value Investing Score
1
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
0
Quarters > 0 > income Statement > operating Expenses
386529
Quarters > 0 > income Statement > operating Income
-386529
Quarters > 0 > income Statement > interest Expense
191974
Quarters > 0 > income Statement > pretax Income
-578503
Quarters > 0 > income Statement > net Income
-578503
Quarters > 0 > income Statement > eps
-0.3603533624812116
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1605377
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
85571
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
85571
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
135571
Quarters > 0 > balance Sheet > payables
773604
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
2063289
Quarters > 0 > balance Sheet > total Liabilities
6052780
Quarters > 0 > balance Sheet > equity
-5917209
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-578503
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
139227
Quarters > 0 > cash Flow > cash From Operations
-199326
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
284438
Quarters > 0 > cash Flow > net Change In Cash
85112
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.3603533624812116
Quarters > 0 > ratios > PB
-0.13565322772949207
Quarters > 0 > ratios > ROE
9.7766193487504
Quarters > 0 > ratios > ROA
-426.7158905665666
Quarters > 0 > ratios > FCF
-199326
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
0
Quarters > 1 > income Statement > operating Expenses
469513
Quarters > 1 > income Statement > operating Income
-469513
Quarters > 1 > income Statement > interest Expense
124065
Quarters > 1 > income Statement > pretax Income
-1451187
Quarters > 1 > income Statement > net Income
-1451187
Quarters > 1 > income Statement > eps
-0.9039540245063932
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1605377
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-857609
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
459
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1759
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
51759
Quarters > 1 > balance Sheet > payables
729846
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5489388
Quarters > 1 > balance Sheet > equity
-5437629
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1451187
Quarters > 1 > cash Flow > depreciation
0
Quarters > 1 > cash Flow > change In Working Capital
1113852
Quarters > 1 > cash Flow > cash From Operations
-152436
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
140000
Quarters > 1 > cash Flow > net Change In Cash
-12436
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.9039540245063932
Quarters > 1 > ratios > PB
-0.14761737146833664
Quarters > 1 > ratios > ROE
26.68786340517163
Quarters > 1 > ratios > ROA
-2803.738480264302
Quarters > 1 > ratios > FCF
-152436
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
0
Quarters > 2 > income Statement > operating Expenses
546059
Quarters > 2 > income Statement > operating Income
-546059
Quarters > 2 > income Statement > interest Expense
122505
Quarters > 2 > income Statement > pretax Income
-668564
Quarters > 2 > income Statement > net Income
-668564
Quarters > 2 > income Statement > eps
-0.41645295777876473
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1605377
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
12895
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
68095
Quarters > 2 > balance Sheet > property Plant Equipment
105503
Quarters > 2 > balance Sheet > total Assets
244309
Quarters > 2 > balance Sheet > payables
672040
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5189516
Quarters > 2 > balance Sheet > equity
-4945207
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-668564
Quarters > 2 > cash Flow > depreciation
1363
Quarters > 2 > cash Flow > change In Working Capital
200698
Quarters > 2 > cash Flow > cash From Operations
-294446
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
295197
Quarters > 2 > cash Flow > net Change In Cash
751
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.41645295777876473
Quarters > 2 > ratios > PB
-0.1623164611713928
Quarters > 2 > ratios > ROE
13.519434070201713
Quarters > 2 > ratios > ROA
-273.6550843399138
Quarters > 2 > ratios > FCF
-294446
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
0
Quarters > 3 > income Statement > operating Expenses
478010
Quarters > 3 > income Statement > operating Income
-478010
Quarters > 3 > income Statement > interest Expense
108523
Quarters > 3 > income Statement > pretax Income
-522818
Quarters > 3 > income Statement > net Income
-522818
Quarters > 3 > income Statement > eps
-0.32566680599011943
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1605377
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
63715
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
12144
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
21244
Quarters > 3 > balance Sheet > property Plant Equipment
121764
Quarters > 3 > balance Sheet > total Assets
213719
Quarters > 3 > balance Sheet > payables
608384
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4671343
Quarters > 3 > balance Sheet > equity
-4457624
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-522818
Quarters > 3 > cash Flow > depreciation
1363
Quarters > 3 > cash Flow > change In Working Capital
149380
Quarters > 3 > cash Flow > cash From Operations
-290218
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
137574
Quarters > 3 > cash Flow > net Change In Cash
-152644
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.32566680599011943
Quarters > 3 > ratios > PB
-0.18007093016369258
Quarters > 3 > ratios > ROE
11.728624935615924
Quarters > 3 > ratios > ROA
-244.62869468788458
Quarters > 3 > ratios > FCF
-290218
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
32
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
0
Annuals > 0 > income Statement > operating Expenses
2519242
Annuals > 0 > income Statement > operating Income
-2519242
Annuals > 0 > income Statement > interest Expense
859915
Annuals > 0 > income Statement > pretax Income
-3340212
Annuals > 0 > income Statement > net Income
-3340212
Annuals > 0 > income Statement > eps
-2.0806402483653375
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1605377
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
38945
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
12144
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
0
Annuals > 0 > balance Sheet > total Current Assets
21244
Annuals > 0 > balance Sheet > property Plant Equipment
121764
Annuals > 0 > balance Sheet > total Assets
213719
Annuals > 0 > balance Sheet > payables
608384
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
4671343
Annuals > 0 > balance Sheet > equity
-4457624
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-3340212
Annuals > 0 > cash Flow > depreciation
5611
Annuals > 0 > cash Flow > change In Working Capital
1264324
Annuals > 0 > cash Flow > cash From Operations
-872436
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
872890
Annuals > 0 > cash Flow > net Change In Cash
454
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.0806402483653375
Annuals > 0 > ratios > PB
-0.6158425811598286
Annuals > 0 > ratios > ROE
74.93256497183253
Annuals > 0 > ratios > ROA
-1562.8989467478325
Annuals > 0 > ratios > FCF
-872436
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
2455317
Annuals > 1 > income Statement > operating Income
-2455317
Annuals > 1 > income Statement > interest Expense
2043584
Annuals > 1 > income Statement > pretax Income
-4145936
Annuals > 1 > income Statement > net Income
-4145936
Annuals > 1 > income Statement > eps
-3.2178576002297397
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1288415
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
352965
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11690
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
50000
Annuals > 1 > balance Sheet > total Current Assets
118063
Annuals > 1 > balance Sheet > property Plant Equipment
183032
Annuals > 1 > balance Sheet > total Assets
321806
Annuals > 1 > balance Sheet > payables
461646
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3734306
Annuals > 1 > balance Sheet > equity
-3412500
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-4145936
Annuals > 1 > cash Flow > depreciation
8856
Annuals > 1 > cash Flow > change In Working Capital
850095
Annuals > 1 > cash Flow > cash From Operations
-1383210
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1386544
Annuals > 1 > cash Flow > net Change In Cash
3334
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.2178576002297397
Annuals > 1 > ratios > PB
-0.6456233406593407
Annuals > 1 > ratios > ROE
121.49263003663005
Annuals > 1 > ratios > ROA
-1288.3339651839929
Annuals > 1 > ratios > FCF
-1383210
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
2147265
Annuals > 2 > income Statement > operating Income
-2147265
Annuals > 2 > income Statement > interest Expense
782552
Annuals > 2 > income Statement > pretax Income
-2929817
Annuals > 2 > income Statement > net Income
-2929817
Annuals > 2 > income Statement > eps
-3.062755920739707
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
956595
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-2272623
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
8356
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
50000
Annuals > 2 > balance Sheet > total Current Assets
70298
Annuals > 2 > balance Sheet > property Plant Equipment
239770
Annuals > 2 > balance Sheet > total Assets
332879
Annuals > 2 > balance Sheet > payables
327517
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2236119
Annuals > 2 > balance Sheet > equity
-1903240
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-2929817
Annuals > 2 > cash Flow > depreciation
10454
Annuals > 2 > cash Flow > change In Working Capital
307007
Annuals > 2 > cash Flow > cash From Operations
-1830242
Annuals > 2 > cash Flow > capital Expenditures
860
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1498502
Annuals > 2 > cash Flow > net Change In Cash
-332600
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.062755920739707
Annuals > 2 > ratios > PB
-0.8594698776822681
Annuals > 2 > ratios > ROE
153.93838927302914
Annuals > 2 > ratios > ROA
-880.1447372769085
Annuals > 2 > ratios > FCF
-1831102
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
2008217
Annuals > 3 > income Statement > operating Income
-2008217
Annuals > 3 > income Statement > interest Expense
460355
Annuals > 3 > income Statement > pretax Income
-3004619
Annuals > 3 > income Statement > net Income
-3004619
Annuals > 3 > income Statement > eps
-0.08056185303209587
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
37295803
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-2525113
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-536047
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
340956
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
50000
Annuals > 3 > balance Sheet > total Current Assets
393031
Annuals > 3 > balance Sheet > property Plant Equipment
290817
Annuals > 3 > balance Sheet > total Assets
710259
Annuals > 3 > balance Sheet > payables
39674
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
974843
Annuals > 3 > balance Sheet > equity
-264584
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-3004619
Annuals > 3 > cash Flow > depreciation
19151
Annuals > 3 > cash Flow > change In Working Capital
-34149
Annuals > 3 > cash Flow > cash From Operations
-1774182
Annuals > 3 > cash Flow > capital Expenditures
29264
Annuals > 3 > cash Flow > cash From Investing
-29264
Annuals > 3 > cash Flow > cash From Financing
2060000
Annuals > 3 > cash Flow > net Change In Cash
256554
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.08056185303209587
Annuals > 3 > ratios > PB
-241.04187377165664
Annuals > 3 > ratios > ROE
1135.6011701387838
Annuals > 3 > ratios > ROA
-423.0314575387288
Annuals > 3 > ratios > FCF
-1803446
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.3603533624812116
Valuation > metrics > PB
-0.13565322772949207
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
9.7766193487504
Profitability > metrics > ROA
-676.0502974138435
Profitability > final Score
35
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-2.013444528946628
Risk > final Score
22
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.1106134404682499
Liquidity > metrics > Quick Ratio
0.1106134404682499
Liquidity > final Score
16
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
42
Prev Profitabilities > 2
38
Prev Risks > 0
15
Prev Risks > 1
12
Prev Risks > 2
12
Prev Liquidities > 0
10
Prev Liquidities > 1
15
Prev Liquidities > 2
12
Updated At
2026-01-20T22:34:14.530Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-05-21
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.4165
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-02-26
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.3257
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-29
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.9434
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-08-13
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.6965
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-05-14
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.6162
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2024-02-28
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.9414
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-15
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.819
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-15
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.6675
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-16
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.3945
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-03-01
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.9127
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-11-15
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7792
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-15
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.7146
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-03-31
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.7272
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2021-12-31
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.3347
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-09-30
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.7254
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-09-30
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.02
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-06-30
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.02
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2021-03-31
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0131
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0131
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2020-09-30
Earnings History > 18 > report Date
2020-12-31
Earnings History > 18 > date
2020-09-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0305
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-09-30
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.592
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-06-30
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.5208
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.5024
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-09-30
Earnings History > 22 > report Date
2019-12-31
Earnings History > 22 > date
2019-09-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
1.1467
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-06-30
Earnings History > 23 > report Date
2019-09-30
Earnings History > 23 > date
2019-06-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.26
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-03-31
Earnings History > 24 > report Date
2019-03-31
Earnings History > 24 > date
2019-03-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
3.9836
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2018-09-30
Earnings History > 25 > report Date
2018-09-30
Earnings History > 25 > date
2018-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-32.6292
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-06-30
Earnings History > 26 > report Date
2018-06-30
Earnings History > 26 > date
2018-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-29.7973
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-03-31
Earnings History > 27 > report Date
2018-03-31
Earnings History > 27 > date
2018-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-76.8712
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2017-12-31
Earnings History > 28 > report Date
2017-12-31
Earnings History > 28 > date
2017-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-134.8726
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2017-09-30
Earnings History > 29 > report Date
2017-09-30
Earnings History > 29 > date
2017-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-187.0788
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2017-06-30
Earnings History > 30 > report Date
2017-06-30
Earnings History > 30 > date
2017-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-130.9425
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-03-31
Earnings History > 31 > report Date
2017-03-31
Earnings History > 31 > date
2017-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-84.2782
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2016-09-30
Earnings History > 32 > report Date
2016-09-30
Earnings History > 32 > date
2016-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-75.4464
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2016-06-30
Earnings History > 33 > report Date
2016-06-30
Earnings History > 33 > date
2016-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-154.4952
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Sigyn Therapeutics, Inc., a development-stage company, develops and sells medical devices to treat cancer and infectious disease disorders in the United States. Its lead product candidate is Sigyn therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community-acquired pneumonia, drug-resistant bacterial infections, and emerging pandemic threats. The company is also involved in the evaluation of Sigyn therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the performance of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AContrasting Grifols (NASDAQ:GRFS) & Sigyn Therapeutics (OTCMKTS:SIGY) Defense World
Read more →Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc. FinancialContent
Read more →Showing 2 of 4
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Sigyn Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-0.4165
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.